1. Home
  2. GNPX
  3. GNPX News

Latest Genprex Inc. (GNPX) News on April 3, 2025

Genprex doses first subject in expansion part of lung cancer gene therapy trial

Clinical Trials Arena

2 months ago

Genprex doses first subject in expansion part of lung cancer gene therapy trial

MT Newswires

5 months ago

Top Premarket Decliners

Business Wire

10 months ago

Form 8.3 - Darktrace plc

Business Wire

10 months ago

Net Asset Value(s)

Share on Social Networks: